Cellectis AB, a subsidiary of Takara Holdings, Inc., is a Swedish company located in Gothenburg. The firm manufactures and distributes stem cell-related products. On September 04, 2014 Takara Bio, Inc. acquired Cellectis AB from Cellectis SA.

Shenzhen Huada Gene Agriculture Holding Co., Ltd., established on 2015-12-15, Business scope includes general business items:Agriculture-related equity investment,Investment Advisory,investment management(not to engage in trust,Financial Asset Management,Securities asset management and other services,according to the law,Administrative regulations,Decisions of the State Council and other regulations that require approval,Can only operate after obtaining relevant approval documents according to law);Invest in business(Specific projects will be reported separately);Mechanical research and development;New products in the field of biotechnology,New Technology,Research and development of new technologies and industrialization of results;New products in the field of circular economy,New Technology,Research and development of new technologies and industrialization of results;Bioenergy engineering and environmental engineering technology project contracting,technology transfer,technical consulting;Purchase and sale of primary agricultural products;Domestic and foreign commodity trade;Operating import and export business;fertilizer,Research and development of pesticides;R&D and sales of daily chemical products and cosmetics.(law,Administrative regulations,Except for items prohibited by the State Council,Restricted projects must obtain a license before operating),The licensing program is:Seed Processing;Processing of primary agricultural products,Deep processing of agricultural products;Storage of agricultural products,delivery;General Food New Products,New Technology,Research and development of new technologies and industrialization of results;Bioenergy Engineering Technology Training;Probiotics Powder,Tablet Candy,Production of solid beverages and other foods.wine,Research and development of vinegar,processing,buy and sell;animal and plant breeding;Seed Production and Breeding;Breeding of new varieties of animals and plants in the field of agriculture,to plant,farming;agriculture,Breeding and product deep processing.purchase and sale of seeds;Import and export of agricultural materials;Import and export of agricultural products;purchase and sale of food,processing,import and export;fertilizer production,buy and sell;pesticide,Purchase and sale of machinery,Production;Seed import and export;functional food,Healthy food,New products of health medicine,New Technology,Research and development of new technologies and industrialization of results;Health food production,buy and sell.health training.(law,Administrative regulations,Except for items prohibited by the State Council,Restricted projects must obtain a license before operating)

Corning, Inc. engages in the provision of glass for notebook computers, flat panel desktop monitors, display televisions, and other information display applications, carrier network and enterprise network products for the telecommunications industry, ceramic substrates for gasoline and diesel engines in automotive and heavy-duty vehicle markets, laboratory products for the scientific community and polymer products for biotechnology applications, optical materials for the semiconductor industry and the scientific community, and polycrystalline silicon products and other technologies. It operates through the following business segments: Display Technologies, Optical Communications, Environmental Technologies, Specialty Materials, and Life Sciences. The Display Technologies segment manufactures glass substrates for flat panel displays, including organic light-emitting diodes and liquid crystal displays that are used primarily in televisions, notebook computer, desktop monitors, tablets, and handheld devices. The Optical Communications segment is classified into two main product groupings: carrier and enterprise network. The carrier network group consists primarily of products and solutions for optical-based communications infrastructure for services such as video, data, and voice communications. The enterprise network group consists primarily of optical-based communication networks sold to businesses, governments, and individuals for their own use. The Environmental Technologies segment manufactures ceramic substrates and filter products for emissions control in mobile and stationary applications. The Specialty Materials segment engages in the manufacture of products that provide material formulations for glass, glass ceramics and crystals, and precision metrology instruments and software. The Life Sciences segment develops, manufactures, and supplies laboratory products. The company was founded by Amory Houghton Sr. in 1851 and is headquartered in Corning, NY.

Huada Ark Biotechnology specializes in research on cloning and transgenic animal production. The company has a cloning technology department, a model animal department, and a transgenic research and development department.

Rheinmetall Air Defence AG engages in the development and manufacture of advanced air defense, simulators, and training systems. It also supplies mobile gun systems, fire control systems, automatic cannon, integrated missile launchers, radar systems, battle management systems, target allocation kits, naval gun systems, multi-sensor tracking modules, three-dimensional search and acquisition radars, Ahead ammunition, and target designation sights. The company was founded on June 26, 1968 and is headquartered in Zurich, Switzerland.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

BGI Shenzhen Co., Ltd. engages in the equity investment and asset management. Its business scope includes research and development and sales of computer hardware and software and peripheral equipment technology; import and export of goods and technology; equity investment; investment in industrial development; and aquatic product farming and sales. The company was founded on August 21, 2008 and is headquartered in Shenzhen, China.

The Institute for Biomathematics and Biometry conducts fundamental research in areas including Epidemiology, Analysis of Complex Experimental Data, Analysis of Environmental Chemicals, Machine Learning, Bacterial Communication Processes in the Rhizosphere, the Regulation Pathway of NF-κB and Coagulation Cascades.

Qiagen Genomics, Inc. provides research and technology in the bioscience area. The company is headquartered in Bothell, WA.

Wuhan Hualianke Biotechnology Co., Ltd., established on 2014-04-10, The scope of business includes technology development in the fields of biology and medicine,technology transfer,technical consulting,Technical Services;biological reagent(Does not contain dangerous goods)research and development,Sales;Animal experiment(Operate within the approved period with the license);Construction of experimental animal models,Research,Technical Services;Instrumentation,laboratory equipment,Green facilities,plastic products,Glass product,Wholesale and retail of Class I medical devices.(Projects subject to approval by law,Business activities can only be carried out after approval by relevant departments)

VIDA International Group CO., Ltd. is a Chinese private company located in Xuhui that provides plastic surgery services.

Henan Greenkins Biotechnology Co., Ltd., established on 2013-06-26, Business scope includes biotechnology development,consult,comminicate,transfer,Promotion service;Import and export of goods or technology;Sales:wine,Pre-packaged food,Electrical Equipment,primary agricultural products,farming equipment.

Seikagaku Corp. manufactures pharmaceuticals and medical devices with glycoconjugates; specifically, glycosaminoglycans (GAG) such as hyaluronic acid; as well as enzymes that act on GAG. It operates through the following segments: Pharmaceuticals and Limulus Amebocyte Lysate (LAL). The Pharmaceuticals segment develops and supplies intra-articular injections for improving joint functions, cross-linked hyaluronate hydrogel for knee osteoarthritis, opthalmic surgical aids, and surgical aids for endoscopic mucosal resection. The LAL segment manufactures and sells endotoxin-detecting reagents in Japan and overseas. The company was founded on June 2, 1947 and is headquartered in Tokyo, Japan.